首页> 外文期刊>Journal of the American Chemical Society >Sensitive NMR Approach for Determining the Binding Mode of Tightly Binding Ligand Molecules to Protein Targets
【24h】

Sensitive NMR Approach for Determining the Binding Mode of Tightly Binding Ligand Molecules to Protein Targets

机译:敏感的NMR方法确定紧密结合的配体分子与蛋白质目标的结合模式。

获取原文
获取原文并翻译 | 示例
       

摘要

Structure-guided drug design relies on detailed structural knowledge of protein-ligand complexes, but crystallization of cocomplexes is not always possible. Here we present a sensitive nuclear magnetic resonance (NMR) approach to determine the binding mode of tightly binding lead compounds in complex with difficult target proteins. In contrast to established NMR methods, it does not depend on rapid exchange between bound and free ligand or on stable isotope labeling, relying instead on a tert-butyl group as a chemical label. tert-Butyl groups are found in numerous protein ligands and deliver an exceptionally narrow and tall ~1H NMR signal. We show that a tert-butyl group also produces outstandingly intense intra- and intermolecular NOESY cross-peaks. These enable measurements of pseudocontact shifts generated by lanthanide tags attached to the protein, which in turn allows positioning of the ligand on the protein. Once the ligand has been located, assignments of intermolecular NOEs become possible even without prior resonance assignments of protein side chains. The approach is demonstrated with the dengue virus NS2B-NS3 protease in complex with a high-affinity ligand containing a tert-butyl group.
机译:结构指导的药物设计依赖于蛋白质-配体复合物的详细结构知识,但共复合物的结晶并非总是可能的。在这里,我们提出了一种敏感的核磁共振(NMR)方法来确定与困难目标蛋白复合的紧密结合的先导化合物的结合方式。与已建立的NMR方法相反,它不依赖于键合和游离配体之间的快速交换,也不依赖于稳定的同位素标记,而是依赖于叔丁基作为化学标记。叔丁基存在于许多蛋白质配体中,并提供异常狭窄且高的〜1H NMR信号。我们表明,叔丁基还产生出色的强度的分子内和分子间NOESY交叉峰。这些可以测量由附着在蛋白质上的镧系元素标签产生的假接触位移,从而允许将配体定位在蛋白质上。一旦定位了配体,即使没有蛋白质侧链的先前共振分配,分子间NOE的分配也变得可能。用登革热病毒NS2B-NS3蛋白酶与含有叔丁基的高亲和力配体复合证明了该方法。

著录项

  • 来源
    《Journal of the American Chemical Society》 |2016年第13期|4539-4546|共8页
  • 作者单位

    Australian National University, Research School of Chemistry, Canberra, ACT 2601, Australia;

    Australian National University, Research School of Chemistry, Canberra, ACT 2601, Australia,Medicinal Chemistry, Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Im Neuenheimer Feld 364, 69120 Heidelberg, Germany;

    Australian National University, Research School of Chemistry, Canberra, ACT 2601, Australia;

    Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia;

    Australian National University, Research School of Chemistry, Canberra, ACT 2601, Australia;

    Medicinal Chemistry, Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Im Neuenheimer Feld 364, 69120 Heidelberg, Germany;

    Australian National University, Research School of Chemistry, Canberra, ACT 2601, Australia;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 03:08:45

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号